How to Choose a Digital Screening Platform for Your Practice

Digital screening platforms have moved from a nice-to-have to a near-standard part of running a modern practice. But "digital screening tool" covers a wide range of products, from a simple online PDF replacement to a fully integrated, FHIR-native assessment system. Choosing the wrong one can mean paying for features you'll never use, or discovering six months in that the platform can't do something your practice actually needs.

Here's a practical framework for evaluating your options.

Start With Instrument Coverage

The most basic question is also the most important: does the platform actually offer the instruments your practice needs?

Check for the instruments you use most. If your intake process centers on PHQ-9, GAD-7, and AUDIT, confirm those are available today, not "coming soon." Platforms differ significantly in how many validated instruments they've actually built versus how many they list as planned.

Understand the licensing status. Public-domain and open-license instruments (PHQ-9, GAD-7, DASS-21, K10, WHO-5, and similar) can typically be deployed immediately. Proprietary instruments (BDI, PAI, NEO, and others from publishers like Pearson, PAR, MHS, or WPS) require the platform to hold a proper publisher license, ask directly whether a given instrument is licensed or planned, and be wary of any platform that's vague about this distinction.

Ask about bring-your-own-license (BYOL) support. If your practice already holds a corporate license for a proprietary instrument, check whether the platform can integrate it without requiring you to pay for a second license.

Verify Real Auto-Scoring, Not Just Digital Delivery

Some platforms digitize the paper form a patient fills out on a screen, but a staff member still has to calculate and enter the score manually. That defeats much of the purpose. Look for:

Instant scoring on submission, with severity bands applied automatically Correct handling of reverse-scored items and any multiplier steps (the DASS-21's ×2 step is a common one platforms get wrong) Automatic flagging of single-item risk indicators, like PHQ-9 item 9 or EPDS item 10 Transparent, inspectable scoring logic ideally documented, not a black box you have to trust blindly Confirm Compliance and Data Residency

For any platform handling protected health information, compliance isn't optional. Before committing, confirm:

Regulatory alignment for your region. HIPAA compliance for US practices, GDPR for EU-based ones, and equivalent frameworks (like Australia's Privacy Act, or APP) for other jurisdictions.

A signed BAA or DPA. A platform should offer a standard Business Associate Agreement (US) or Data Processing Agreement (EU) as a matter of course, not as a custom negotiation.

Data residency options. If your patients' data needs to physically stay within a specific region (EU, US, Australia, or elsewhere), confirm the platform supports region-pinning rather than defaulting to a single data center that may not meet your regulatory obligations.

Encryption and access control. Ask specifically about per-tenant encryption keys and row-level security — generic assurances of "bank-level encryption" without specifics are a red flag.

Check Integration With Your Existing Systems

A screening platform that lives entirely on its own, disconnected from your EHR, creates exactly the kind of manual re-entry work that automation is supposed to eliminate.

FHIR R4 support. The ability to export results as standard FHIR QuestionnaireResponse and Observation resources means scores flow directly into most modern EHRs without custom integration work.

API access. For practices with more complex workflows, confirm whether the platform offers an API for custom integrations, not just a fixed export format.

Existing EHR partnerships. Some platforms have pre-built integrations with specific EHR vendors — worth checking if your practice already uses a major system.

Evaluate the Clinician and Patient Experience

Technical capability matters little if the day-to-day experience is clunky. When evaluating a platform hands-on, pay attention to:

How fast a clinician can assign and review an assessment, this should take seconds, not multiple menu screens Whether trend charts across repeated administrations are automatic or require manual chart pulling The patient-facing experience is the questionnaire clear, accessible, and usable on a phone, given how many patients will complete it outside a clinical setting Load and response times — a platform that lags during a live session creates friction that discourages routine use Consider Pricing Structure Carefully

Screening platform pricing varies widely in structure, not just amount:

Per-seat vs. per-practice pricing: understand whether cost scales with every staff member or just clinical users What's included at each tier public-domain catalog access, FHIR export, and AI-assisted features often sit behind different pricing tiers Licensed instrument add-ons: if you'll eventually need proprietary instruments, check how that's priced separately Contract flexibility: month-to-month vs. annual commitments, and what happens to your data if you cancel Look for Transparency About What's Live vs. Planned

Especially for newer platforms building out large instrument catalogs, it's worth asking directly: how many instruments are actually usable today, versus on a roadmap? A platform that's upfront about "43 instruments live, 130 in the licensing pipeline," for example, is giving you an honest basis for comparison — versus a marketing page that lists every instrument under the sun without clarifying which ones you can actually use on day one.

A Quick Evaluation Checklist

Before signing a contract, confirm the platform can answer yes to each of these:

Does it include the specific instruments my practice needs, available today? Does it auto-score correctly, including reverse-scored items and risk flags? Does it offer a signed BAA/DPA and clear data residency options? Can it export to my EHR via FHIR or a documented API? Is the clinician workflow fast enough to use at every visit, not just occasionally? Is the pricing structure clear about what's included at each tier?

Final Thoughts:

Choosing a digital screening platform isn't just about picking the most feature-rich option—it's about matching a platform's current, available capabilities to your practice's specific instrument needs, compliance obligations, and existing workflow. A platform that's honest about what's live today versus what's coming, and that treats scoring transparency and data compliance as non-negotiable, is a much safer long-term bet than one that leads with a flashy feature list and vague assurances.